Table 2.
Baseline characteristics of CAD and NCAD groups.
| Variables | CAD group (n = 26) | NCAD group (n = 20) | χ2/Z | p |
|---|---|---|---|---|
| Male (%) | 14 (53.8) | 8 (40.0) | 0.869 | 0.351 |
| Age (years) | 62 (51, 67) | 61 (58, 63) | − 1.055 | 0.292 |
| Body mass index (kg/m2) | 25.5 ± 3.1 | 23.7 ± 3.8 | 1.929 | 0.062 |
| Chest pain (%) | 20 (76.9) | 2 (10.0) | 20.290 | < 0.001 |
| Smoking (%) | 9 (34.6) | 4 (20.0) | 1.191 | 0.275 |
| Hypertension (%) | 16 (61.5) | 5 (25.0) | 6.038 | 0.014 |
| Diabetes (%) | 11 (42.3) | 2 (10.0) | 5.820 | 0.016 |
| Dyslipidemia (%) | 14 (58.3) | 11 (64.7) | 0.170 | 0.680 |
| Ischemic stroke (%) | 9 (34.6) | 2 (10.0) | 3.765 | 0.052 |
| Uric acid (mmol/L) | 297.4 ± 100.4 | 398.8 ± 122.1 | − 2.905 | 0.006 |
| Blood urea nitrogen (mmol/L) | 5.40 ± 1.43 | 6.85 ± 1.83 | − 2.789 | 0.008 |
| Creatinine (μmol/L) | 65.5 ± 16.3 | 67.6 ± 16.5 | − 0.380 | 0.706 |
| Aspirin (%) | 24 (92.3) | 1 (5.6) | 204.000 | < 0.001 |
| β-R inhibitor (%) | 12 (46.2) | 11 (61.1) | 0.545 | 0.329 |
| Statin (%) | 24 (92.3) | 3 (16.7) | 25.669 | < 0.001 |
| ACEI/ARB (%) | 6 (23.1) | 2 (11.1) | 1.024 | 0.312 |